Anticoagulants Market Size to Hit USD 43,427 million by 2025: Analysis of Key Players, Trends, Drivers, & Challenges

The Anticoagulants market dynamics, forces, companies and trends have been determined after conducting a detailed study of the industry for this newly released research report now available with Big Market Research.
$43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025.

Anticoagulants, commonly known as blood thinners, are chemical substances that prevent or reduce coagulation of blood and prolong the clotting time. The market has different types of anticoagulant drugs, and each drug works by inhibiting various pathways of blood coagulation. These drugs are majorly used for high risk of blood clots, such as atrial fibrillation, deep vein thrombosis, myocardial infarction, pulmonary embolism, stroke, and others.

The global anticoagulants market is expected to grow at a significant rate during the forecast period, owing to increasing prevalence of venous thromboembolism (VTE) and cardiovascular disease across the world, growing adoption of novel oral anticoagulants (NOACs), and growing awareness of NOACs in developing regions. Furthermore, increasing obese and geriatric population and growing demand of novel therapeutics are anticipated to further influence the market growth during the forecast period. On the other side, higher price of NOACs and lack of antidots for NOACs impede the market growth.

Request for a sample copy of this report @ https://www.bigmarketresearch.com/request-sample/2658372

The global anticoagulants market is segmented based on drug class, route of administration, application, and region. On the basis of drug class, the anticoagulants market is classified as NOACs, heparin & LMWH, vitamin K antagonist, and others. As per the route of administration, the market is segmented as oral anticoagulant and injectable anticoagulant. Application market-wise, it is classified as atrial fibrillation & heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and others.

According to region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Request for a Discount of this report @ https://www.bigmarketresearch.com/request-for-discount/2658372

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Aspen Holdings, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, GlaxoSmithKline plc, Johnson & Johnson (Janssen Pharmaceuticals, Inc.), Pfizer, Inc, Portola Pharmaceuticals, Inc and Sanofi S.A.

By route of administration

Oral anticoagulant

Injectable anticoagulant

By application

Atrial fibrillation & heart attack

Stroke

Deep vein thrombosis (DVT)

Pulmonary embolism (PE)

Others

Table of content:

CHAPTER 4: ANTICOAGULANTS MARKET, BY DRUG CLASS

4.1. Overview

4.1.1. Market size and forecast

4.2. NOACs

4.2.1. Key market trends, growth factors, and opportunities

4.2.2. Market size and forecast, by type

4.2.2.1. Eliquis market size and forecast

4.2.2.2. Bevyxxa market size and forecast

4.2.2.3. Xarelto market size and forecast

4.2.2.4. Savaysa & Lixiana market size and forecast

4.2.2.5. Pradaxa market size and forecast

4.2.3. Market size and forecast, by region

4.2.4. Market analysis, by country

4.3. Heparins & LMWH

4.3.1. Key market trends, growth factors, and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market analysis, by country

4.4. Vitamin K Antagonists

4.4.1. Key market trends, growth factors, and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market analysis, by country

4.5. Other Anticoagulant Drugs

4.5.1. Key market trends, growth factors, and opportunities

4.5.2. Market size and forecast, by region

4.5.3. Market analysis, by country

For More: https://www.bigmarketresearch.com/anticoagulant-drugs-market

About Us:

Industry executives tend to keep a tab on their business competitors. This keeps them updated on strategic business activities and investment trends. Company profiles are crucial to participating players of interconnected verticals.

Contact Us:

5933 NE Win Sivers Drive, #205, Portland,

OR 97220 United States

call answer Direct:+1-971-202-1575

call answer Toll Free:+1-800-910-6452

email help@bigmarketresearch.com

This release was published on openPR.